![](/timesofindia.indiatimes.com/toiitpic/30409/images/9/78fcf145dcf2dd6203e595314ee99bc4_1524137828644_0.jpg)
marketwatch: "new migraine drugs have promise -- and a ,500 price tag." . http://lm360.us/Boney-sister-of-Bostic-from-Suceava?Obiesiebr=121
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .